The postpartum shed actually begins with a change that most people experience as a positive one. Elevated oestrogen during pregnancy extends the anagen (growth) phase of the hair cycle, meaning a higher-than-usual proportion of scalp follicles stay in active growth for longer than they normally would. Fewer hairs than usual progress to telogen (resting) and shed on the ordinary schedule, so hair accumulates: many pregnant women notice their hair feels thicker and fuller as pregnancy progresses, not because more hair is growing, but because less of it is falling out.

This matters for understanding what comes next: the postpartum shed is not a new problem appearing from nowhere. It is the delayed, synchronised release of hair that would have shed gradually over the preceding months if oestrogen levels hadn't held it in place.

After delivery, oestrogen and other pregnancy hormones drop sharply. The follicles that had been held in an extended anagen phase lose that hormonal support all at once, and a disproportionate number shift into telogen simultaneously. Because hair sheds roughly two to three months after a follicle enters telogen, the visible result, a sudden and often alarming increase in daily shedding, typically appears around three to four months after birth rather than immediately.

This is postpartum telogen effluvium: the same underlying mechanism covered in the article on telogen effluvium vs androgenetic alopecia, triggered specifically by the abrupt hormonal withdrawal after childbirth rather than a nutritional, thyroid, or stress-related cause. It is diffuse rather than patterned, meaning shedding is spread across the scalp rather than concentrated at the hairline or crown, and it does not involve the follicle miniaturisation seen in androgenetic alopecia.

It's worth noting that not every researcher agrees postpartum telogen effluvium is as sharply defined a clinical entity as the widely cited timeline above suggests. At least one literature review has questioned whether objective studies consistently show a statistically significant shedding difference between pregnant and postpartum women at all, arguing the condition may be less clearly delineated than commonly described. This is a minority position against a large body of clinical literature and everyday clinical experience, and it doesn't change the practical guidance here, but it's a reasonable reminder that "textbook" timelines in hair biology are usually averages drawn from variable individual experience, not fixed rules.

Postpartum shedding is usually described, correctly, as temporary and self-resolving. What is less often mentioned is that pregnancy and the postpartum period can also unmask a hair loss condition, most often androgenetic alopecia, that was already present but not yet obvious. A 2024 dermoscopic evaluation of 200 women presenting with postpartum hair loss found that only a small minority had pure telogen effluvium alone; the majority showed telogen effluvium alongside signs of androgenetic alopecia, traction alopecia, or both.

This doesn't mean postpartum shedding is usually something more serious. It means the sudden, visible nature of postpartum TE can bring attention to a slower, quieter process, most often early androgenetic alopecia, that had been present for longer but was easy to overlook before the acute shed made hair loss impossible to ignore. It is also why traction alopecia, hair loss caused by tension from tight hairstyles or postpartum styling habits, sometimes gets attributed entirely to hormones when tension at the hairline is a contributing factor.

Practically, this is a reason to pay attention to the pattern of shedding, not just its presence. Diffuse thinning that improves steadily after the 3 to 6 month peak is consistent with typical postpartum TE. Thinning that is concentrated at the temples or crown, that doesn't meaningfully improve by 9 to 12 months, or that was arguably present even before pregnancy, is worth a closer look rather than being assumed to be hormonal and temporary by default.

Several factors around childbirth and the months that follow can compound the core hormonal trigger, either extending the shedding period or increasing its severity.

Most postpartum shedding follows the pattern described above and doesn't require intervention beyond time, and where relevant, addressing an identified nutritional or thyroid contributor. A GP or midwife appointment is worth arranging if any of the following apply: shedding hasn't noticeably improved by around 9 to 12 months postpartum, hair loss is patterned rather than diffuse (concentrated at the temples, crown, or hairline rather than spread evenly), there are other symptoms alongside the shedding such as persistent fatigue, heart palpitations, or unexplained weight change, or the hair loss feels disproportionately severe relative to what's typically described as postpartum shedding.

None of this is intended to cause alarm about what is, for the overwhelming majority of women, a temporary and self-limiting experience. It's simply worth knowing what would justify moving from watchful waiting to an actual check-up, particularly given how demanding early parenthood already is without also carrying uncertainty about whether something needs medical attention.

Because postpartum shedding is a cycle disruption rather than follicle damage, the affected follicles are still fully capable of producing hair; the process largely runs its own course once the hormonal trigger settles. That said, a few practical measures are reasonable during the shedding window: gentle hair handling (avoiding tight hairstyles or aggressive brushing on hair that may already be more fragile mid-shed), addressing any identified nutritional gaps such as low ferritin under medical guidance, and simply expecting the timeline described above rather than assuming worsening shedding at 4 months means something has gone wrong.

On pharmaceutical hair loss treatments specifically: finasteride and dutasteride are contraindicated during pregnancy and should not be used by anyone who is or may become pregnant, due to the risk of feminisation of a male foetus, and this extends to avoiding even incidental handling of the medication. Their use while breastfeeding has not been adequately studied and should only be considered, if at all, in direct consultation with a doctor. Minoxidil's safety during pregnancy and breastfeeding is also not well established for the oral form in particular, and any use during this period should be a decision made with a healthcare provider rather than self-directed.

Topical cosmetic actives such as copper peptides or 2-Deoxy-D-Ribose have not been specifically studied for safety during pregnancy or breastfeeding either, since this population is routinely excluded from cosmetic ingredient safety trials as a matter of standard practice, not because of any known specific risk. This is a gap in the evidence rather than a red flag, but it means the honest answer is that dedicated safety data doesn't exist, and anyone pregnant or breastfeeding who wants to start a new topical hair product should raise it with their midwife, GP, or health visitor first rather than assume it is automatically fine because it is applied topically and cosmetic in nature. We've written a dedicated, honest breakdown of this exact question for our own copper peptide serum in is AHK-Cu safe for postpartum hair loss?

Because hair growth is inherently slow and cyclical, even once shedding tapers off, visible regrowth and a return to prior density takes further months on top of that, often with a noticeable "halo" of shorter regrowth hairs around the hairline as new anagen hairs come through. This is a normal and encouraging sign that the cycle has restarted, not a separate problem. The article on how long before you see results from a hair loss serum covers the general timeline logic behind why hair-related changes take months rather than weeks to become visible, which applies here as much as it does to any topical intervention.

This article is provided for educational purposes and does not constitute medical advice. If you are pregnant, breastfeeding, or have concerns about postpartum hair loss, consult a qualified healthcare professional before starting any new supplement, medication, or topical product. AmpleLab products are cosmetic formulations and are not intended to diagnose, treat, cure, or prevent any condition, and have not been specifically evaluated for use during pregnancy or breastfeeding.

AmpleLab.